🇺🇸 Iberet-Folic-500 in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 9

Most-reported reactions

1. Bladder Distension — 1 report (11.11%)
2. Blood Glucose Increased — 1 report (11.11%)
3. Blood Urine — 1 report (11.11%)
4. Cerebrovascular Accident — 1 report (11.11%)
5. Nausea — 1 report (11.11%)
6. Prostate Examination Abnormal — 1 report (11.11%)
7. Renal Failure Acute — 1 report (11.11%)
8. Suspected Counterfeit Product — 1 report (11.11%)
9. Vomiting — 1 report (11.11%)

Source database →

Frequently asked questions

Is Iberet-Folic-500 approved in United States?

Iberet-Folic-500 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Iberet-Folic-500 in United States?

University of Malaya is the originator. The local marketing authorisation holder may differ — check the official source linked above.